David Zebrowski
Founder & Chief Executive Officer GenKardia
Seminars
Wednesday 28th January 2026
Conquering Cardiac Fibrosis: A New RNAi Paradigm for Heart Failure
10:00 am
- Leveraging highly specific RNAi therapeutics, directly silencing key pro-fibrotic genes, to halt the underlying disease progression and move beyond symptom management
- Utilizing a novel, targeted delivery platform, enabling efficient extrahepatic delivery to cardiac tissue, to achieve robust efficacy and open new treatment possibilities for patients
- Addressing the root cause of pathological remodeling, by precisely reducing fibrosis and hypertrophy, to restore cardiac function and significantly improve patient quality of life
